Otago Exercise Program for Fall Risk Reduction After Hip Fracture
Trial Summary
What is the purpose of this trial?
This trial tests if doing specific exercises at home can help older adults with mild cognitive issues who have broken their hip from a fall. The goal is to see if these exercises can make them stronger and better at balancing to prevent future falls.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you are on anti-dementia medications, you should be stable on a fixed dose for more than 3 months before joining the trial.
What data supports the effectiveness of the Otago Exercise Program treatment for reducing fall risk after hip fracture?
Is the Otago Exercise Program safe for humans?
How is the Otago Exercise Program treatment different from other treatments for reducing fall risk after hip fracture?
The Otago Exercise Program is unique because it is a home-based exercise program focused on improving strength, balance, and walking to prevent falls, specifically tailored for older adults. Unlike other treatments, it can be delivered through a DVD for minimal supervision, making it accessible for those in rural or assisted living settings.12589
Research Team
Jennifer C Davis, PhD
Principal Investigator
University of British Columbia
Deborha Jehu, PhD
Principal Investigator
University of British Columbia
Larry Dian, MD
Principal Investigator
University of British Columbia
Teresa Liu-Ambrose, PhD
Principal Investigator
University of British Columbia
Pierre Guy, MD
Principal Investigator
University of British Columbia
Eligibility Criteria
This trial is for adults aged 65 or older who have had a fall-related hip fracture within the last year, can walk a short distance with or without help, and have mild cognitive issues but no dementia. They must be able to communicate in English and not be on certain dementia medications.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the Otago Exercise Program or usual care for 6 months
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Otago Exercise Program
- Usual Care
Otago Exercise Program is already approved in United States for the following indications:
- Fall prevention in older adults
- Used in research studies for fall prevention in tribal communities
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of British Columbia
Lead Sponsor
Amgen
Industry Sponsor
Robert A. Bradway
Amgen
Chief Executive Officer since 2012
MBA from Harvard Business School
Paul Burton
Amgen
Chief Medical Officer since 2023
MD from University of London, PhD in Molecular and Cellular Biology from Imperial College London